Biosurgical Hemostatic Agents

Poor bleeding control leads to untoward patient outcomes and increases the risk of morbidity and mortality. Some 29.9% of surgical procedures experience bleeding complications, resulting in an average of six additional hospital days. Hemostats, while not a substitute for surgical technique, are a tool used by surgeons to control surgical bleeding. This document provides an overview of these products, clinical practice guidance and current evidence regarding their use.

Please Register or Login

You must be logged in to access exclusive content within our clinical resources.

Register Log-in